< 0 1 0 1 O
12 2 4 2 4 B-upper_bound
months 5 11 5 11 I-upper_bound
( 12 13 12 13 O
< 13 14 13 14 O
365 15 18 15 18 B-upper_bound
days 19 23 19 23 I-upper_bound
) 23 24 23 24 O
of 25 27 25 27 O
age 28 31 28 31 B-age
at 32 34 32 34 O
diagnosis 35 44 35 44 O
with 45 49 45 49 O
INRG 50 54 50 54 B-cancer
stage 55 60 55 60 I-cancer
L1 61 63 61 63 I-cancer

< 0 1 64 65 O
12 2 4 66 68 B-upper_bound
months 5 11 69 75 I-upper_bound
of 12 14 76 78 O
age 15 18 79 82 B-age
with 19 23 83 87 O
a 24 25 88 89 O
non 26 29 90 93 B-clinical_variable
- 29 30 93 94 I-clinical_variable
adrenal 30 37 94 101 I-clinical_variable
primary 38 45 102 109 I-clinical_variable
site 46 50 110 114 I-clinical_variable
< 51 52 115 116 O
5 53 54 117 118 B-upper_bound
cm 55 57 119 121 I-upper_bound
in 58 60 122 124 I-upper_bound
greatest 61 69 125 133 I-upper_bound
diameter 70 78 134 142 I-upper_bound

< 0 1 143 144 O
18 2 4 145 147 B-upper_bound
months 5 11 148 154 I-upper_bound
( 12 13 155 156 O
< 13 14 156 157 O
547 15 18 158 161 B-upper_bound
days 19 23 162 166 I-upper_bound
) 23 24 166 167 O
of 25 27 168 170 O
age 28 31 171 174 B-age
at 32 34 175 177 O
diagnosis 35 44 178 187 O
with 45 49 188 192 O
INRG 50 54 193 197 O
stage 55 60 198 203 O
L2 61 63 204 206 O
or 64 66 207 209 O
stage 67 72 210 215 O
Ms 73 75 216 218 O
neuroblastoma 76 89 219 232 B-cancer
/ 89 90 232 233 O
ganglioneuroblastoma 90 110 233 253 B-cancer

= 0 1 254 255 O
< 1 2 255 256 O
6 3 4 257 258 B-upper_bound
months 5 11 259 265 I-upper_bound
of 12 14 266 268 O
age 15 18 269 272 B-age
with 19 23 273 277 O
an 24 26 278 280 O
adrenal 27 34 281 288 B-clinical_variable
primary 35 42 289 296 I-clinical_variable
site 43 47 297 301 I-clinical_variable
and 48 51 302 305 I-clinical_variable
tumor 52 57 306 311 I-clinical_variable
= 58 59 312 313 O
< 59 60 313 314 O
3.1 61 64 315 318 B-upper_bound
cm 65 67 319 321 I-upper_bound
in 68 70 322 324 O
greatest 71 79 325 333 O
diameter 80 88 334 342 O

> 0 1 343 344 O
6 2 3 345 346 B-lower_bound
months 4 10 347 353 I-lower_bound
and 11 14 354 357 O
< 15 16 358 359 O
12 17 19 360 362 B-upper_bound
months 20 26 363 369 I-upper_bound
of 27 29 370 372 O
age 30 33 373 376 B-age
with 34 38 377 381 O
an 39 41 382 384 O
adrenal 42 49 385 392 O
primary 50 57 393 400 B-cancer
tumor 58 63 401 406 I-cancer
< 64 65 407 408 O
5 66 67 409 410 B-upper_bound
cm 68 70 411 413 I-upper_bound
in 71 73 414 416 O
greatest 74 82 417 425 O
diameter 83 91 426 434 O

Enrollment 0 10 435 445 O
on 11 13 446 448 O
ANBL00B1 14 22 449 457 B-treatment
or 23 25 458 460 O
APEC14B1 26 34 461 469 B-treatment
is 35 37 470 472 O
required 38 46 473 481 O
for 47 50 482 485 O
all 51 54 486 489 O
newly 55 60 490 495 O
diagnosed 61 70 496 505 O
patients 71 79 506 514 O

Greatest 0 8 515 523 O
tumor 9 14 524 529 B-clinical_variable
diameter 15 23 530 538 I-clinical_variable
< 24 25 539 540 O
5 26 27 541 542 B-upper_bound
cm 28 30 543 545 I-upper_bound
of 31 33 546 548 O
adrenal 34 41 549 556 O
or 42 44 557 559 O
non 45 48 560 563 O
- 48 49 563 564 O
adrenal 49 56 564 571 O
origin 57 63 572 578 O

Group 0 5 579 584 O
A 6 7 585 586 O
and 8 11 587 590 O
C 12 13 591 592 O
patients 14 22 593 601 O
, 22 23 601 602 O
not 24 27 603 606 O
required 28 36 607 615 O
to 37 39 616 618 O
undergo 40 47 619 626 O
tumor 48 53 627 632 B-cancer
biopsy 54 60 633 639 B-treatment
, 60 61 639 640 O
who 62 65 641 644 O
do 66 68 645 647 O
not 69 72 648 651 O
enroll 73 79 652 658 O
on 80 82 659 661 O
ANBL1232 83 91 662 670 O
within 92 98 671 677 O
4 99 100 678 679 B-upper_bound
weeks 101 106 680 685 I-upper_bound
of 107 109 686 688 O
confirmatory 110 122 689 701 O
imaging 123 130 702 709 O
study 131 136 710 715 O

Group 0 5 716 721 O
B 6 7 722 723 O
and 8 11 724 727 O
C 12 13 728 729 O
patients 14 22 730 738 O
who 23 26 739 742 O
do 27 29 743 745 O
not 30 33 746 749 O
enroll 34 40 750 756 O
on 41 43 757 759 O
ANBL1232 44 52 760 768 O
within 53 59 769 775 O
4 60 61 776 777 B-upper_bound
weeks 62 67 778 783 I-upper_bound
of 68 70 784 786 O
definitive 71 81 787 797 O
diagnostic 82 92 798 808 O
procedure 93 102 809 818 O

No 0 2 819 821 O
life 3 7 822 826 O
threatening 8 19 827 838 O
symptoms 20 28 839 847 O
or 29 31 848 850 O
no 32 34 851 853 O
impending 35 44 854 863 O
neurologic 45 55 864 874 O
or 56 58 875 877 O
other 59 64 878 883 O
organ 65 70 884 889 O
function 71 79 890 898 O
compromise 80 90 899 909 O
( 91 92 910 911 O
e.g. 92 96 911 915 O
epidural 97 105 916 924 B-cancer
or 106 108 925 927 O
intraspinal 109 120 928 939 B-cancer
tumors 121 127 940 946 I-cancer
with 128 132 947 951 O
existing 133 141 952 960 O
or 142 144 961 963 O
impending 145 154 964 973 O
neurologic 155 165 974 984 B-chronic_disease
impairment 166 176 985 995 I-chronic_disease
, 176 177 995 996 O
periorbital 178 189 997 1008 O
or 190 192 1009 1011 O
calvarial 193 202 1012 1021 O
- 202 203 1021 1022 O
based 203 208 1022 1027 O
lesions 209 216 1028 1035 O
with 217 221 1036 1040 O
existing 222 230 1041 1049 O
or 231 233 1050 1052 O
impending 234 243 1053 1062 O
cranial 244 251 1063 1070 B-chronic_disease
nerve 252 257 1071 1076 I-chronic_disease
impairment 258 268 1077 1087 I-chronic_disease
, 268 269 1087 1088 O
anatomic 270 278 1089 1097 O
or 279 281 1098 1100 O
mechanical 282 292 1101 1111 O
compromise 293 303 1112 1122 O
of 304 306 1123 1125 O
critical 307 315 1126 1134 O
organ 316 321 1135 1140 O
function 322 330 1141 1149 O
by 331 333 1150 1152 O
tumor 334 339 1153 1158 O
[ 340 341 1159 1160 O
abdominal 341 350 1160 1169 B-chronic_disease
compartment 351 362 1170 1181 I-chronic_disease
syndrome 363 371 1182 1190 I-chronic_disease
, 371 372 1190 1191 O
urinary 373 380 1192 1199 B-chronic_disease
obstruction 381 392 1200 1211 I-chronic_disease
, 392 393 1211 1212 O
etc 394 397 1213 1216 O
. 397 398 1216 1217 O
] 398 399 1217 1218 O
) 399 400 1218 1219 O
; 400 401 1219 1220 O
horner 402 408 1221 1227 B-chronic_disease
syndrome 409 417 1228 1236 I-chronic_disease
is 418 420 1237 1239 O
not 421 424 1240 1243 O
considered 425 435 1244 1254 O
neurologic 436 446 1255 1265 O
compromise 447 457 1266 1276 O

No 0 2 1277 1279 O
prior 3 8 1280 1285 B-treatment
radiotherapy 9 21 1286 1298 I-treatment
or 22 24 1299 1301 O
chemotherapy 25 37 1302 1314 B-treatment
, 37 38 1314 1315 O
with 39 43 1316 1320 O
the 44 47 1321 1324 O
exception 48 57 1325 1334 O
of 58 60 1335 1337 O
dexamethasone 61 74 1338 1351 B-treatment
, 74 75 1351 1352 O
which 76 81 1353 1358 O
is 82 84 1359 1361 O
allowed 85 92 1362 1369 O

No 0 2 1370 1372 O
prior 3 8 1373 1378 B-treatment
tumor 9 14 1379 1384 I-treatment
resection 15 24 1385 1394 I-treatment
or 25 27 1395 1397 O
biopsy 28 34 1398 1404 B-treatment

No 0 2 1405 1407 O
prior 3 8 1408 1413 B-treatment
tumor 9 14 1414 1419 I-treatment
resection 15 24 1420 1429 I-treatment
, 24 25 1429 1430 O
tumor 26 31 1431 1436 B-treatment
biopsy 32 38 1437 1443 I-treatment
ONLY 39 43 1444 1448 O

Only 0 4 1449 1453 O
patients 5 13 1454 1462 O
with 14 18 1463 1467 O
MYCN 19 23 1468 1472 B-cancer
non 24 27 1473 1476 I-cancer
- 27 28 1476 1477 I-cancer
amplified 28 37 1477 1486 I-cancer
tumors 38 44 1487 1493 I-cancer

Patients 0 8 1494 1502 O
less 9 13 1503 1507 O
than 14 18 1508 1512 O
6 19 20 1513 1514 B-upper_bound
months 21 27 1515 1521 I-upper_bound
of 28 30 1522 1524 O
age 31 34 1525 1528 B-age
with 35 39 1529 1533 O
an 40 42 1534 1536 O
adrenal 43 50 1537 1544 B-cancer
primary 51 58 1545 1552 I-cancer
tumor 59 64 1553 1558 I-cancer
> 65 66 1559 1560 O
3.1 67 70 1561 1564 B-lower_bound
and 71 74 1565 1568 O
< 75 76 1569 1570 O
5 77 78 1571 1572 B-upper_bound
cm 79 81 1573 1575 I-upper_bound
in 82 84 1576 1578 O
greatest 85 93 1579 1587 O
diameter 94 102 1588 1596 O

Patients 0 8 1597 1605 O
must 9 13 1606 1610 O
have 14 18 1611 1615 O
newly 19 24 1616 1621 O
diagnosed 25 34 1622 1631 O
v 35 36 1632 1633 O
- 36 37 1633 1634 O
myc 37 40 1634 1637 O
avian 41 46 1638 1643 O
myelocytomatosis 47 63 1644 1660 B-cancer
viral 64 69 1661 1666 O
oncogene 70 78 1667 1675 O
neuroblastoma 79 92 1676 1689 B-cancer
derived 93 100 1690 1697 O
homolog 101 108 1698 1705 O
( 109 110 1706 1707 O
MYCN 110 114 1707 1711 O
) 114 115 1711 1712 O
non 116 119 1713 1716 O
- 119 120 1716 1717 O
amplified 120 129 1717 1726 O
neuroblastoma 130 143 1727 1740 O
( 144 145 1741 1742 O
International 145 158 1742 1755 O
Classification 159 173 1756 1770 O
of 174 176 1771 1773 O
Diseases 177 185 1774 1782 O
for 186 189 1783 1786 O
Oncology 190 198 1787 1795 O
[ 199 200 1796 1797 O
ICD 200 203 1797 1800 O
- 203 204 1800 1801 O
O 204 205 1801 1802 O
] 205 206 1802 1803 O
morphology 207 217 1804 1814 O
9500/3 218 224 1815 1821 O
) 224 225 1821 1822 O
or 226 228 1823 1825 O
MYCN 229 233 1826 1830 O
non 234 237 1831 1834 O
- 237 238 1834 1835 O
amplified 238 247 1835 1844 O
ganglioneuroblastoma 248 268 1845 1865 B-cancer
verified 269 277 1866 1874 O
by 278 280 1875 1877 O
histology 281 290 1878 1887 O

Patients 0 8 1888 1896 O
must 9 13 1897 1901 O
meet 14 18 1902 1906 O
the 19 22 1907 1910 O
specified 23 32 1911 1920 O
criteria 33 41 1921 1929 O
for 42 45 1930 1933 O
one 46 49 1934 1937 O
of 50 52 1938 1940 O
the 53 56 1941 1944 O
treatment 57 66 1945 1954 B-treatment
groups 67 73 1955 1961 O
defined 74 81 1962 1969 O
below 82 87 1970 1975 O
; 87 88 1975 1976 O
genomic 89 96 1977 1984 O
features 97 105 1985 1993 O
include 106 113 1994 2001 O
MYCN 114 118 2002 2006 O
gene 119 123 2007 2011 O
amplification 124 137 2012 2025 O
, 137 138 2025 2026 O
segmental 139 148 2027 2036 O
chromosome 149 159 2037 2047 O
aberrations 160 171 2048 2059 O
( 172 173 2060 2061 O
somatic 173 180 2061 2068 O
copy 181 185 2069 2073 O
number 186 192 2074 2080 O
loss 193 197 2081 2085 O
at 198 200 2086 2088 O
1p 201 203 2089 2091 O
, 203 204 2091 2092 O
3p 205 207 2093 2095 O
, 207 208 2095 2096 O
4p 209 211 2097 2099 O
, 211 212 2099 2100 O
or 213 215 2101 2103 O
11q 216 219 2104 2107 O
or 220 222 2108 2110 O
somatic 223 230 2111 2118 O
copy 231 235 2119 2123 O
number 236 242 2124 2130 O
gain 243 247 2131 2135 O
at 248 250 2136 2138 O
1q 251 253 2139 2141 O
, 253 254 2141 2142 O
2p 255 257 2143 2145 O
, 257 258 2145 2146 O
or 259 261 2147 2149 O
17q 262 265 2150 2153 O
) 265 266 2153 2154 O
and 267 270 2155 2158 O
deoxyribonucleic 271 287 2159 2175 O
acid 288 292 2176 2180 O
( 293 294 2181 2182 O
DNA 294 297 2182 2185 O
) 297 298 2185 2186 O
index 299 304 2187 2192 O

Patients 0 8 2193 2201 O
with 9 13 2202 2206 O
MYCN 14 18 2207 2211 O
amplified 19 28 2212 2221 O
tumors 29 35 2222 2228 B-cancer

Patients 0 8 2229 2237 O
with 9 13 2238 2242 O
non 14 17 2243 2246 O
- 17 18 2246 2247 O
adrenal 18 25 2247 2254 O
primaries 26 35 2255 2264 O
are 36 39 2265 2268 O
eligible 40 48 2269 2277 O
, 48 49 2277 2278 O
but 50 53 2279 2282 O
must 54 58 2283 2287 O
have 59 63 2288 2292 O
positive 64 72 2293 2301 O
uptake 73 79 2302 2308 O
on 80 82 2309 2311 O
metaiodobenzylguanidine 83 106 2312 2335 B-treatment
( 107 108 2336 2337 I-treatment
MIBG 108 112 2337 2341 I-treatment
) 112 113 2341 2342 I-treatment
scan 114 118 2343 2347 O
or 119 121 2348 2350 O
elevated 122 130 2351 2359 O
catecholamine 131 144 2360 2373 B-clinical_variable
metabolites 145 156 2374 2385 O
( 157 158 2386 2387 O
urine 158 163 2387 2392 O
or 164 166 2393 2395 O
serum 167 172 2396 2401 O
) 172 173 2401 2402 O
to 174 176 2403 2405 O
support 177 184 2406 2413 O
the 185 188 2414 2417 O
diagnosis 189 198 2418 2427 O
of 199 201 2428 2430 O
neuroblastoma 202 215 2431 2444 B-cancer

genomic 0 7 2445 2452 O
features 8 16 2453 2461 O
are 17 20 2462 2465 O
defined 21 28 2466 2473 O
by 29 31 2474 2476 O
one 32 35 2477 2480 B-lower_bound
or 36 38 2481 2483 O
more 39 43 2484 2488 O
whole 44 49 2489 2494 O
- 49 50 2494 2495 O
chromosome 50 60 2495 2505 O
gains 61 66 2506 2511 O
or 67 69 2512 2514 O
hyperdiploid 70 82 2515 2527 B-cancer
tumor 83 88 2528 2533 I-cancer
( 89 90 2534 2535 O
DNA 90 93 2535 2538 B-clinical_variable
index 94 99 2539 2544 I-clinical_variable
> 100 101 2545 2546 O
1 102 103 2547 2548 B-lower_bound
) 103 104 2548 2549 O
in 105 107 2550 2552 O
the 108 111 2553 2556 O
absence 112 119 2557 2564 O
of 120 122 2565 2567 O
segmental 123 132 2568 2577 O
chromosome 133 143 2578 2588 O
aberrations 144 155 2589 2600 O

genomic 0 7 2601 2608 O
features 8 16 2609 2617 O
are 17 20 2618 2621 O
defined 21 28 2622 2629 O
by 29 31 2630 2632 O
the 32 35 2633 2636 O
presence 36 44 2637 2645 O
of 45 47 2646 2648 O
any 48 51 2649 2652 O
segmental 52 61 2653 2662 B-chronic_disease
chromosome 62 72 2663 2673 I-chronic_disease
aberration 73 83 2674 2684 I-chronic_disease
( 84 85 2685 2686 O
somatic 85 92 2686 2693 O
copy 93 97 2694 2698 O
number 98 104 2699 2705 O
loss 105 109 2706 2710 O
at 110 112 2711 2713 O
1p 113 115 2714 2716 O
, 115 116 2716 2717 O
3p 117 119 2718 2720 O
, 119 120 2720 2721 O
4p 121 123 2722 2724 O
, 123 124 2724 2725 O
or 125 127 2726 2728 O
11q 128 131 2729 2732 O
or 132 134 2733 2735 O
somatic 135 142 2736 2743 O
copy 143 147 2744 2748 O
number 148 154 2749 2755 O
gain 155 159 2756 2760 O
at 160 162 2761 2763 O
1q 163 165 2764 2766 O
, 165 166 2766 2767 O
2p 167 169 2768 2770 O
, 169 170 2770 2771 O
or 171 173 2772 2774 O
17q 174 177 2775 2778 O
) 177 178 2778 2779 O
or 179 181 2780 2782 O
diploid 182 189 2783 2790 B-cancer
tumor 190 195 2791 2796 I-cancer
( 196 197 2797 2798 O
DNA 197 200 2798 2801 B-clinical_variable
index 201 206 2802 2807 I-clinical_variable
= 207 208 2808 2809 O
1 209 210 2810 2811 O
) 210 211 2811 2812 O
; 211 212 2812 2813 O
this 213 217 2814 2818 O
includes 218 226 2819 2827 O
copy 227 231 2828 2832 O
neutral 232 239 2833 2840 O
loss 240 244 2841 2845 O
of 245 247 2846 2848 O
heterozygosity 248 262 2849 2863 O
( 263 264 2864 2865 O
LOH 264 267 2865 2868 O
) 267 268 2868 2869 O

patients 0 8 2870 2878 O
< 9 10 2879 2880 O
12 11 13 2881 2883 B-upper_bound
months 14 20 2884 2890 I-upper_bound
( 21 22 2891 2892 O
< 22 23 2892 2893 O
365 24 27 2894 2897 B-upper_bound
days 28 32 2898 2902 I-upper_bound
) 32 33 2902 2903 O
of 34 36 2904 2906 O
age 37 40 2907 2910 B-age
with 41 45 2911 2915 O
newly 46 51 2916 2921 O
diagnosed 52 61 2922 2931 O
INRG 62 66 2932 2936 O
stage 67 72 2937 2942 O
L1 73 75 2943 2945 O
neuroblastoma 76 89 2946 2959 B-cancer
/ 89 90 2959 2960 O
ganglioneuroblastoma 90 110 2960 2980 B-cancer

patients 0 8 2981 2989 O
< 9 10 2990 2991 O
18 11 13 2992 2994 B-upper_bound
months 14 20 2995 3001 I-upper_bound
( 21 22 3002 3003 O
< 22 23 3003 3004 O
547 24 27 3005 3008 B-upper_bound
days 28 32 3009 3013 I-upper_bound
) 32 33 3013 3014 O
of 34 36 3015 3017 O
age 37 40 3018 3021 B-age
with 41 45 3022 3026 O
newly 46 51 3027 3032 O
diagnosed 52 61 3033 3042 O
INRG 62 66 3043 3047 O
stage 67 72 3048 3053 O
L2 73 75 3054 3056 O
neuroblastoma 76 89 3057 3070 B-cancer
/ 89 90 3070 3071 O
ganglioneuroblastoma 90 110 3071 3091 B-cancer

patients 0 8 3092 3100 O
< 9 10 3101 3102 O
18 11 13 3103 3105 B-upper_bound
months 14 20 3106 3112 I-upper_bound
( 21 22 3113 3114 O
< 22 23 3114 3115 O
547 24 27 3116 3119 B-upper_bound
days 28 32 3120 3124 I-upper_bound
) 32 33 3124 3125 O
of 34 36 3126 3128 O
age 37 40 3129 3132 B-age
with 41 45 3133 3137 O
newly 46 51 3138 3143 O
diagnosed 52 61 3144 3153 O
INRG 62 66 3154 3158 O
stage 67 72 3159 3164 O
Ms 73 75 3165 3167 O
neuroblastoma 76 89 3168 3181 B-cancer
/ 89 90 3181 3182 O
ganglioneuroblastoma 90 110 3182 3202 B-cancer

